Cargando…

First person – Emily Koller

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Emily Koller is first author on ‘ Temporal and spatially controlled APP transgene expressio...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150104/
http://dx.doi.org/10.1242/dmm.049602
_version_ 1784717353231056896
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Emily Koller is first author on ‘ Temporal and spatially controlled APP transgene expression using Cre-dependent alleles’, published in DMM. Emily is a postdoctoral associate in the lab of Joanna Jankowsky, PhD at Baylor College of Medicine, Houston, TX, USA, investigating the impact of ageing in Alzheimer's disease, and is also interested in developing therapeutic interventions for diseases of the brain.
format Online
Article
Text
id pubmed-9150104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-91501042022-05-31 First person – Emily Koller Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Emily Koller is first author on ‘ Temporal and spatially controlled APP transgene expression using Cre-dependent alleles’, published in DMM. Emily is a postdoctoral associate in the lab of Joanna Jankowsky, PhD at Baylor College of Medicine, Houston, TX, USA, investigating the impact of ageing in Alzheimer's disease, and is also interested in developing therapeutic interventions for diseases of the brain. The Company of Biologists Ltd 2022-05-16 /pmc/articles/PMC9150104/ http://dx.doi.org/10.1242/dmm.049602 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Emily Koller
title First person – Emily Koller
title_full First person – Emily Koller
title_fullStr First person – Emily Koller
title_full_unstemmed First person – Emily Koller
title_short First person – Emily Koller
title_sort first person – emily koller
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150104/
http://dx.doi.org/10.1242/dmm.049602